Eversept Partners, LP Merus N.V. Transaction History

Eversept Partners, LP

  • $1.33 Billion
  • Q1 2024

A detailed history of Eversept Partners, LP transactions in Merus N.V. stock. As of the latest transaction made, Eversept Partners, LP holds 119,482 shares of MRUS stock, worth $6.34 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
119,482
Previous 115,726 3.25%
Holding current value
$6.34 Million
Previous $3.18 Million 69.08%
% of portfolio
0.4%
Previous 0.31%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$28.03 - $51.82 $105,280 - $194,635
3,756 Added 3.25%
119,482 $5.38 Million
Q4 2023

Feb 14, 2024
SELL
$20.06 - $28.66 $366,777 - $524,019
-18,284 Reduced 13.64%
115,726 $3.18 Million
Q3 2023

Nov 14, 2023
BUY
$20.13 - $27.29 $56,041 - $75,975
2,784 Added 2.12%
134,010 $3.16 Million
Q2 2023

Nov 08, 2023
BUY
$18.33 - $27.18 $39,776 - $58,980
2,170 Added 1.68%
131,226 $3.46 Million
Q2 2023

Aug 14, 2023
BUY
$18.33 - $27.18 $39,776 - $58,980
2,170 Added 1.68%
131,226 $3.46 Million
Q1 2023

Nov 08, 2023
SELL
$14.25 - $20.5 $790,875 - $1.14 Million
-55,500 Reduced 30.07%
129,056 $2.37 Million
Q1 2023

May 15, 2023
SELL
$14.25 - $20.5 $790,875 - $1.14 Million
-55,500 Reduced 30.07%
129,056 $2.37 Million
Q4 2022

Nov 08, 2023
SELL
$12.8 - $23.66 $1.18 Million - $2.18 Million
-92,117 Reduced 33.29%
184,556 $2.86 Million
Q4 2022

Feb 14, 2023
SELL
$12.8 - $23.66 $1.18 Million - $2.18 Million
-92,117 Reduced 33.29%
184,556 $2.86 Million
Q3 2022

Nov 08, 2023
SELL
$18.64 - $28.93 $207,519 - $322,077
-11,133 Reduced 3.87%
276,673 $5.54 Million
Q3 2022

Nov 14, 2022
SELL
$18.64 - $28.93 $207,519 - $322,077
-11,133 Reduced 3.87%
276,673 $5.54 Million
Q2 2022

Nov 08, 2023
BUY
$13.98 - $29.25 $2.95 Million - $6.17 Million
210,957 Added 274.51%
287,806 $6.52 Million
Q2 2022

Aug 15, 2022
BUY
$13.98 - $29.25 $2.95 Million - $6.17 Million
210,957 Added 274.51%
287,806 $6.52 Million
Q1 2022

Nov 08, 2023
SELL
$23.58 - $30.91 $1.28 Million - $1.68 Million
-54,377 Reduced 41.44%
76,849 $2.03 Million
Q1 2022

May 16, 2022
BUY
$23.58 - $30.91 $1.36 Million - $1.79 Million
57,849 Added 304.47%
76,849 $2.03 Million
Q4 2021

Nov 08, 2023
BUY
$20.0 - $32.29 $91,100 - $147,080
4,555 Added 31.53%
19,000 $604,000
Q4 2021

Feb 14, 2022
BUY
$20.0 - $32.29 $380,000 - $613,510
19,000 New
19,000 $604,000
Q1 2021

May 13, 2021
SELL
$16.14 - $29.11 $233,142 - $420,493
-14,445 Closed
0 $0
Q4 2020

Nov 08, 2023
SELL
$11.4 - $18.36 $1.33 Million - $2.14 Million
-116,781 Reduced 88.99%
14,445 $253,000
Q4 2020

Feb 16, 2021
BUY
$11.4 - $18.36 $164,673 - $265,210
14,445 New
14,445 $253,000

Others Institutions Holding MRUS

# of Institutions
164
Shares Held
47.9M
Call Options Held
123K
Put Options Held
293K
View Full List

About Merus N.V.

MRUS Quotes by TradingView
  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.44B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email